236 related articles for article (PubMed ID: 17998494)
1. Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study.
Odden MC; Scherzer R; Bacchetti P; Szczech LA; Sidney S; Grunfeld C; Shlipak MG
Arch Intern Med; 2007 Nov; 167(20):2213-9. PubMed ID: 17998494
[TBL] [Abstract][Full Text] [Related]
2. Cystatin C and creatinine in an HIV cohort: the nutrition for healthy living study.
Jones CY; Jones CA; Wilson IB; Knox TA; Levey AS; Spiegelman D; Gorbach SL; Van Lente F; Stevens LA
Am J Kidney Dis; 2008 Jun; 51(6):914-24. PubMed ID: 18455851
[TBL] [Abstract][Full Text] [Related]
3. Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons.
Choi A; Scherzer R; Bacchetti P; Tien PC; Saag MS; Gibert CL; Szczech LA; Grunfeld C; Shlipak MG
Am J Kidney Dis; 2010 Nov; 56(5):872-82. PubMed ID: 20709438
[TBL] [Abstract][Full Text] [Related]
4. Cystatin C as a risk factor for outcomes in chronic kidney disease.
Menon V; Shlipak MG; Wang X; Coresh J; Greene T; Stevens L; Kusek JW; Beck GJ; Collins AJ; Levey AS; Sarnak MJ
Ann Intern Med; 2007 Jul; 147(1):19-27. PubMed ID: 17606957
[TBL] [Abstract][Full Text] [Related]
5. Cystatin C and the risk of death and cardiovascular events among elderly persons.
Shlipak MG; Sarnak MJ; Katz R; Fried LF; Seliger SL; Newman AB; Siscovick DS; Stehman-Breen C
N Engl J Med; 2005 May; 352(20):2049-60. PubMed ID: 15901858
[TBL] [Abstract][Full Text] [Related]
6. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.
Shlipak MG; Katz R; Sarnak MJ; Fried LF; Newman AB; Stehman-Breen C; Seliger SL; Kestenbaum B; Psaty B; Tracy RP; Siscovick DS
Ann Intern Med; 2006 Aug; 145(4):237-46. PubMed ID: 16908914
[TBL] [Abstract][Full Text] [Related]
7. Does HAART improve renal function? An association between serum cystatin C concentration, HIV viral load and HAART duration.
Jaroszewicz J; Wiercinska-Drapalo A; Lapinski TW; Prokopowicz D; Rogalska M; Parfieniuk A
Antivir Ther; 2006; 11(5):641-5. PubMed ID: 16964834
[TBL] [Abstract][Full Text] [Related]
8. Serum cystatin C level as a potentially good marker for impaired kidney function.
Uzun H; Ozmen Keles M; Ataman R; Aydin S; Kalender B; Uslu E; Simsek G; Halac M; Kaya S
Clin Biochem; 2005 Sep; 38(9):792-8. PubMed ID: 16005452
[TBL] [Abstract][Full Text] [Related]
9. Kidney function of HIV-infected children in Lagos, Nigeria: using Filler's serum cystatin C-based formula.
Esezobor CI; Iroha E; Oladipo O; Onifade E; Soriyan OO; Akinsulie AO; Temiye EO; Ezeaka C
J Int AIDS Soc; 2010 May; 13():17. PubMed ID: 20482807
[TBL] [Abstract][Full Text] [Related]
10. Fetuin-A and kidney function in persons with coronary artery disease--data from the Heart and Soul Study.
Ix JH; Chertow GM; Shlipak MG; Brandenburg VM; Ketteler M; Whooley MA
Nephrol Dial Transplant; 2006 Aug; 21(8):2144-51. PubMed ID: 16644775
[TBL] [Abstract][Full Text] [Related]
11. Analysis of glomerular filtration rate, serum cystatin C levels, and renal resistive index values in cirrhosis patients.
Ustundag Y; Samsar U; Acikgoz S; Cabuk M; Kiran S; Kulah E; Aydemir S
Clin Chem Lab Med; 2007; 45(7):890-4. PubMed ID: 17617033
[TBL] [Abstract][Full Text] [Related]
12. Cystatin C and aging success.
Sarnak MJ; Katz R; Fried LF; Siscovick D; Kestenbaum B; Seliger S; Rifkin D; Tracy R; Newman AB; Shlipak MG;
Arch Intern Med; 2008 Jan; 168(2):147-53. PubMed ID: 18227360
[TBL] [Abstract][Full Text] [Related]
13. Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study.
Deo R; Fyr CL; Fried LF; Newman AB; Harris TB; Angleman S; Green C; Kritchevsky SB; Chertow GM; Cummings SR; Shlipak MG;
Am Heart J; 2008 Jan; 155(1):62-8. PubMed ID: 18082491
[TBL] [Abstract][Full Text] [Related]
14. Serum cystatin C concentration as a marker of renal dysfunction in the elderly.
Fliser D; Ritz E
Am J Kidney Dis; 2001 Jan; 37(1):79-83. PubMed ID: 11136171
[TBL] [Abstract][Full Text] [Related]
15. Cystatin C concentration as a risk factor for heart failure in older adults.
Sarnak MJ; Katz R; Stehman-Breen CO; Fried LF; Jenny NS; Psaty BM; Newman AB; Siscovick D; Shlipak MG;
Ann Intern Med; 2005 Apr; 142(7):497-505. PubMed ID: 15809461
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of serum cystatin C by ELISA for estimation of glomerular filtration rate.
Xu X; Zou J; Ding X; Xin D; Ren Y
J Clin Lab Anal; 2004; 18(2):61-4. PubMed ID: 15065209
[TBL] [Abstract][Full Text] [Related]
17. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease.
Malyszko J; Bachorzewska-Gajewska H; Malyszko JS; Pawlak K; Dobrzycki S
Nephrology (Carlton); 2008 Apr; 13(2):153-6. PubMed ID: 18275504
[TBL] [Abstract][Full Text] [Related]
18. Chronic kidney disease and estimates of kidney function in HIV infection: a cross-sectional study in the multicenter AIDS cohort study.
Estrella MM; Parekh RS; Astor BC; Bolan R; Evans RW; Palella FJ; Jacobson LP
J Acquir Immune Defic Syndr; 2011 Aug; 57(5):380-6. PubMed ID: 21646913
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of cystatin C and serum creatinine in the estimative of glomerular filtration rate in children.
Cordeiro VF; Pinheiro DC; Silva GB; Lima JW; Mota RM; Libório AB; Daher EF
Clin Chim Acta; 2008 May; 391(1-2):46-50. PubMed ID: 18298952
[TBL] [Abstract][Full Text] [Related]
20. Serum cystatin C concentration as a marker of glomerular filtration rate in patients with various renal diseases.
Nitta K; Hayashi T; Uchida K; Honda K; Tsukada M; Sekine S; Itabashi M; Yumura W; Nihei H
Intern Med; 2002 Nov; 41(11):931-5. PubMed ID: 12487162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
